Clinical Trial to Evaluate the Efficacy and Safety of Conjuran® After First and Second Cycle (Repeat) Administration in Patients With Knee Osteoarthritis
Starting soon · Not applicable
Conditions studied: Knee Osteoarthritis
In brief
This clinical trial aims to evaluate and compare the efficacy and safety of Conjuran® and Hyruan in patients with knee osteoarthritis following first and second cycle (repeat) administration.
Key facts
- Study ID
- NCT07646483
- Run by
- PharmaResearch Co.,Ltd
- People needed
- 180
- Starts
- 2026-06-01
- Expected to finish
- 2028-07-01
- Last updated by the study team
- 2026-06-12
Who can join
Age: 40 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age ≥40 years
- Knee osteoarthritis diagnosed according to ACR criteria
- KL grade I-III
- Weight-bearing pain VAS ≥40 mm
- Written informed consent
You may not qualify if…
- Inflammatory or secondary arthritis
- Recent treatment in the target knee
- Significant uncontrolled medical conditions
- Hypersensitivity to study device components
- Pregnancy or breastfeeding
- Participation in another clinical trial
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.